Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia

Biagi, 1991, Gamma-linolenic acid supplementation can reverse the aging influence on rat liver microsome delta-6-desaturase activity, Biochim. Biophys. Acta, 1083, 187, 10.1016/0005-2760(91)90041-F Blosser, 1978, Neurotransmitter modulation of prostaglandin E1 stimulated increases in cyclic AMP, Biochem. Pharmacol., 27, 1167, 10.1016/0006-2952(78)90447-1 Christensen, 1988, Fat consumption and schizophrenia, Acta Psychiatr. Scand., 78, 587, 10.1111/j.1600-0447.1988.tb06388.x Clerc-Hoffman, 1983, Inhibition of the uterine binding of estrogens by unsaturated fatty acids in the immature rat, C.R. Acad. Sci. Paris, 296, 53 Feldberg, 1976, Possible association of schizophrenia with a disturbance in prostaglandin metabolism: a physiological hypothesis, Psychol. Med., 6, 359, 10.1017/S0033291700015798 Goodfriend, 1986, Fatty acid effects of angiotensin receptors, J. Cardiovasc. Pharmacol., 8, 1276, 10.1097/00005344-198611000-00027 Hedqvist, 1976, Effects of prostaglandins on autonomic neurotransmission, 37 Ho, 1982, Reduction of opioid binding in neuroblastoma x glioma cells grown in medium containing unsaturated fatty acids, Biochim. Biophys. Acta, 688, 211, 10.1016/0005-2736(82)90596-X Horrobin, 1977, Schizophrenia as a prostaglandin deficiency disease, Lancet, i, 1936 Horrobin, 1979, Schizophrenia: reconciliation of the dopamine, prostaglandin and opioid concepts and the role of the pineal, Lancet, i, 529, 10.1016/S0140-6736(79)90948-6 Horrobin, 1985, Essential fatty acids and prostaglandins in schizophrenia and alcoholism, 1163 Horrobin, 1988, The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus, Prostaglandins Leukotrienes Essent. Fatty Acids, 31, 181 Horrobin, 1989-1991 Horrobin, 1989, Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism, Prostaglandins Leukotrienes Essent. Fatty Acids, 37, 255, 10.1016/0952-3278(89)90036-7 Horrobin, 1977, Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action, Prostaglandins, 14, 103, 10.1016/0090-6980(77)90158-7 Horrobin, 1978, Prostaglandins and schizophrenia: further discussion of the evidence, Psychol. Med., 8, 843, 10.1017/S0033291700006619 Horrobin, 1989, Essential fatty acids in plasma phospholipids in schizophrenics, Biol. Psychiatry, 25, 562, 10.1016/0006-3223(89)90216-3 Horrobin, 1991 Horton, 1964, Actions of prostaglandins E1, E2 and E3 on the central nervous system, Br. J. Pharmacol., 22, 189 Kaiya, 1991, Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan, Biol. Psychiatry, 30, 357, 10.1016/0006-3223(91)90291-S Manku, 1977, Effects of prostaglandins on baseline pressure and responses to noradrenaline in a perfused rat mesenteric artery preparation, Prostaglandins, 13, 701, 10.1016/0090-6980(77)90242-8 Manku, 1983, Fatty acids in plasma and red cell membranes in normal humans, Lipids, 18, 906, 10.1007/BF02534572 Masek, 1976, Effect of intracisternal administration of prostaglandin E1 on walking and sleeping in the rat, Neuropharmacology, 15, 491, 10.1016/0028-3908(76)90060-5 Mitsuhashi, 1986, Inhibition of the binding of R-5020 and rat uterine progesterone receptors by long chain fatty acids, Endocrinol. Jpn., 33, 251, 10.1507/endocrj1954.33.251 Suddath, 1990, Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia, New Engl. J. Med., 322, 794, 10.1056/NEJM199003223221201 Vaddadi, 1988, A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia, Psychiatry Res., 27, 313, 10.1016/0165-1781(89)90146-7 Van Kammen, 1989, Polyunsaturated fatty acids, prostaglandins and schizophrenia, Ann. N.Y. Acad. Sci., 559, 411, 10.1111/j.1749-6632.1989.tb22626.x Virkkunen, 1987, Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent and impulsive offenders, Biol. Psychiatry, 22, 1087, 10.1016/0006-3223(87)90051-5 World Health Organisation, 1979